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 Abstract 
 Objective: To assess the associations between obesity markers (BMI, waist circumference and 
%body fat) and inflammatory markers (interleukin-1  (IL-1  ); interleukin-6 (IL-6); tumor ne-
crosis factor-  (TNF-  ) and high-sensitivity C-reactive protein (hs-CRP)).  Methods: Population 
sample of 2,884 men and 3,201 women aged 35–75 years. Associations were assessed using 
ridge regression adjusting for age, leisure-time physical activity, and smoking.  Results: No 
differences were found in IL-1  levels between participants with increased obesity markers 
and healthy counterparts; multivariate regression showed %body fat to be negatively associ-
ated with IL-1  . Participants with high %body fat or abdominal obesity had higher IL-6 levels, 
but no independent association between IL-6 levels and obesity markers was found on mul-
tivariate regression. Participants with abdominal obesity had higher TNF-  levels, and positive 
associations were found between TNF-  levels and waist circumference in men and between 
TNF-  levels and BMI in women. Obese participants had higher hs-CRP levels, and these dif-
ferences persisted after multivariate adjustment; similarly, positive associations were found 
between hs-CRP levels and all obesity markers studied.  Conclusion: Obesity markers are dif-
ferentially associated with cytokine levels. %Body fat is negatively associated with IL-1  ; BMI 
(in women) and waist circumference (in men) are associated with TNF-  ; all obesity markers 
are positively associated with hs-CRP.  Copyright © 2012 S. Karger GmbH, Freiburg 
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 Introduction 
 Cytokines, such as interleukin 1  (IL-1  ), interleukin 6 (IL-6), tumor necrosis factor 
(TNF-  ) and C-reactive protein (CRP) have important effects in inflammation and athero-
sclerosis. Elevated proinflammatory cytokine levels and high-sensitive CRP (hs-CRP) have 
been associated with an increased risk of developing coronary heart disease  [1] or diabetes 
 [2] .
 It has been suggested that obesity is a chronic inflammatory condition  [3] , with 
increased production of cytokines and hs-CRP by adipocytes  [4] . Still, the effects of each 
obesity marker (BMI, waist circumference or %body fat) on cytokine levels remain to be 
clarified. For instance, BMI does not differentiate between lean and fat mass  [5] , while waist 
circumference relates only to the abdominal accumulation of fat. Further, most studies 
which assessed the independent effects of each obesity marker on cytokine levels did so by 
multivariate linear regression  [6, 7] , a method that might lead to inflated estimates when 
multicollinearity (i.e. correlation) of the independent variables (i.e. obesity markers) exists. 
Multicollinearity can distort the interpretation of a model by increased inaccuracy of the 
regression coefficients and their standard errors  [8] . Regression coefficients biased by 
collinearity might cause variables that have no significant relationship with the outcome 
(i.e. cytokine levels) when considered in isolation to become highly significant in conjunction 
with collinear variables, thus increasing type I error (false-positive results). Multiple 
regression coefficients might also show no statistical significance due to large confidence 
intervals, thus increasing type II error (false-negative results).
 Hence, we used the data from the large, population-based CoLaus study to assess the 
association of different obesity markers with cytokine levels by ridge regression, a method 
whose goal is to circumvent the problem of collinearity between independent variables  [9] . 
To our knowledge, this is currently the largest population study that has cytokine levels 
measured.
 Participants and Methods 
 Recruitment 
 The CoLaus Study was approved by the Institutional Ethics Committee of the University of Lausanne. 
The CoLaus Study is a cross-sectional study aimed at assessing the prevalence and identifying the 
molecular determinants of cardiovascular risk factors in the Caucasian population of Lausanne, Swit-
zerland, a town of 117,161 inhabitants, of which 79,420 are of Swiss nationality. The sampling procedure 
of the CoLaus Study has been described previously  [10] . Briefly, the complete list of Lausanne inhabitants 
aged 35–75 years (n = 56,694) was provided by the population registry of the city. A simple, nonstratified 
random sample of 35% of the overall population was drawn. The following inclusion criteria were applied: 
i) written informed consent; ii) age 35–75 years; iii) willingness to take part in the examination and to 
donate blood samples; iv) Caucasian origin, defined as having both parents and grandparents born in a 
restricted list of countries (available from the authors). Recruitment began in June 2003 and ended in May 
2006. Participation rate was 41%.
 All participants attended the outpatient clinic of the University Hospital of Lausanne in the morning 
after an overnight fast. Data were collected by trained field interviewers in a single visit lasting about 60 
min.
 Lifestyle and Clinical Data 
 According to their smoking histories, participants were classified as never, current, or former 
smokers. Leisure-time physical activity was considered if the participant took part for at least 20 min in 
leisure physical activities (tennis, running, football) two or more times per week.
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 Anthropometric Measurements and Bioimpedance 
 Body weight and height were measured with participants standing without shoes in light indoor 
clothes. Body weight was measured in kilograms to the nearest 100 g using a Seca  scale, which was cali-
brated regularly. Height was measured to the nearest 5 mm using a Seca  height gauge. Overweight was 
defined as a BMI  6 25 and  ! 30 kg/m 2 ; obesity was defined as a BMI  6 30 kg/m 2 .
 Waist circumference was measured with a non-stretchable tape over the unclothed abdomen at the 
narrowest point between the lowest rib and the iliac crest. Two measures were made and the mean 
(expressed in centimeters) was used for analyses. Abdominal obesity was considered for a waist circum-
ference  1 102 cm for men and  1 88 cm for women  [11] .
 Body composition was assessed by electrical bioelectrical impedance analysis (BIA) using the 
Bodystat  1500 analyzer (Isle of Man, British Isles, UK). This device has been validated against reference 
methods  [12] . The coefficient of variation for repeated measurements of electrical impedance is 0.7% 
 [12] ; the reproducibility has been shown to be between 1%  [12] and 5%  [13] ; the intraclass correlation 
coefficient has been estimated at 0.99  [14] , and its correlation with reference methods such as isotope 
dilution is between 0.86  [13] and 0.96  [15] . All metallic adornments were removed, and measurement 
was performed after a 10-min rest in the supine position. Care was taken that the subject did not touch 
any metallic component of the bed and that the inner part of the thighs did not touch each other. The 
electrodes were positioned in the right side of the body according to the manufacturer’s recommenda-
tions: injecting leads were connected to the electrodes behind the finger and toe, whereas measuring 
leads were connected to the electrodes on the wrist and ankle. Measurement was conducted with a test 
current of 400   A (root mean square) at a frequency of 50 kHz, with an impedance measuring range of 
30–1,000   (accuracy 3   ). Conversely, no information was available regarding the equation used 
(proprietary). Body fat was expressed as percentage of total body weight (%body fat), and participants 
in the highest sex-specific quartile ( 1 28% in men and  1 40% in women) were considered as presenting 
with high body fat.
 Cytokine Measurement 
 Venous blood samples (50 ml) were drawn in the fasting state. hs-CRP was assessed by immunoassay 
and latex HS (IMMULITE 1000-High, Diagnostic Products Corporation, Los Angeles, CA, USA) with 
maximum intra- and interbatch coefficients of variation of 1.3% and 4.6%, respectively. Serum was 
preferred to plasma as it has been shown that different anticoagulants may affect absolute cytokine levels 
differently  [16] . It has also been stated that cytokine levels in a single blood sample may be useful 
biomarkers of inflammation in population-based studies of obesity-related diseases  [16] . Serum samples 
were kept at –80 ° C before assessment of the other cytokines and sent on dry ice to the laboratory. Cytokine 
levels were measured using a multiplexed particle-based flow cytometric cytokine assay, a methodology 
used in other studies  [17] . Milliplex kits were purchased from Millipore (Zug, Switzerland). The proce-
dures closely followed the manufacturer’s instructions. The analysis was conducted using a conventional 
flow cytometer (FC500 MPL, BeckmanCoulter, Nyon, Switzerland). Lower detection limits for IL-1  , IL-6, 
and TNF-  were 0.2 pg/ml in each case. Data regarding agreement between signal and cytokine levels, 
intra- and interassay coefficients of variation and correlation between repeated measurements have been 
reported elsewhere  [18] .
 Statistical Analysis 
 Statistical analysis was conducted using SAS v.9.2 (SAS Inc, Cary, NC, USA), stratifying by gender. 
Quantitative variables (apart from inflammatory biomarkers) were expressed as mean  8 standard devi-
ation and qualitative variables as number of participants and percentage. Inflammatory biomarkers were 
presented as percentage of values below detection limit, median and interquartile range of measured 
values, and as exponentiated multivariate-adjusted mean  8 standard error. Undetectable values were 
included in the first quartile. Between groups comparisons were performed using Student’s t-test or 
Kruskall-Wallis nonparametric test for quantitative and chi-square test for qualitative variables. The 
bivariate association between cytokines and obesity markers was assessed by Spearman nonparametric 
correlation.
 The association between the different obesity markers (BMI, waist circumference, and %body fat) 
and inflammatory biomarkers was assessed by multivariate analysis including all obesity markers in the 
same model. As age, leisure-time physical activity, and smoking have been associated with cytokine levels, 
they were included in all multivariate models. The association of each obesity marker taken separately 
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was assessed by multivariate linear regression on log-transformed values of detectable IL-1  , Il-6, TNF-  , 
and hs-CRP. As BMI, waist circumference, and %body fat  are closely associated, their independent asso-
ciations with inflammatory markers were assessed in a second multivariate analysis using ridge regression 
applied on all obesity markers. Ridge regression is a variant of ordinary multiple linear regression whose 
goal is to circumvent the problem of predictors’ collinearity  [9] . When the predictor variables are highly 
correlated amongst themselves, the coefficients of the resulting least squares fit may be very imprecise. 
By allowing a small amount of bias in the estimates, more reasonable coefficients may often be obtained. 
Briefly, ridge regression implies that a constant number   (penalty) is added to the elements on the 
diagonal of the matrix to be inverted. Let X be an n  ! (p + 1) matrix of the p independent variables obtained 
in n subjects; let X T be the transposed matrix of X; let Y be an n  ! 1 vector corresponding to the dependent 
variable (i.e. IL-1  levels). The usual linear regression estimates (  values) are obtained via the matrix 
product (X T  ! X) –1  ! X T  ! Y. The ridge regression estimates are obtained via the matrix product (X T  ! 
X +   I) –1  ! X T  ! Y, where I is the p  ! p identity matrix, X is an n  ! p matrix of the centered independent 
variables, and   is the penalty. It has been shown that ridge regression estimators have smaller mean 
square error than the ordinary least-squares estimators, provided   is small enough  [19] . Prior to analysis, 
the effect on the variance inflation factor (VIF) of ridge parameter values from 0 to 0.24 was assessed for 
each gender and the value of 0.18 (corresponding to a VIF close to unity) was chosen. Statistical signifi-
cance was considered for p  ! 0.05.
 Results 
 Clinical Characteristics of Participants 
 Of the 6,188 initial participants, 103 (1.7%) were excluded because of missing cytokine 
data, and a further 55 (0.9%) because of missing data for at least one of the anthropometric 
markers. The clinical characteristics of the remaining 6,030 (2,863 men and 3,167 women) 
are summarized in  table 1 . Men were significantly younger, had a higher BMI, and smoked 
more than women. Conversely, no gender differences were found for leisure-time physical 
activity.
 Among the 6,030 participants, 2,289 (37.6%), 451 (7.4%) and 43 (0.7%) had IL-1  , IL-6 
and TNF-  levels below detection limits, respectively. The distribution of IL-1  , IL-6, TNF-  , 
and hs-CRP levels stratified by gender according to the different obesity markers studied 
are summarized in  tables 2 and  3 . 
 Associations between Obesity Markers and Cytokine Levels 
 Men with high BMI had lower IL-1  levels, but this association was no longer significant 
after multivariate analysis ( table 2 ). In women, high %body fat and abdominal obesity were 
associated with lower IL-1  levels, but this association was no longer significant after multi-
variate adjustment ( table 2 ). %Body fat and waist circumference (men only) were signifi-
cantly and negatively correlated with IL-1  levels, while no association was found for BMI 
( table 4 ). On multivariate ridge regression, %body fat was independently and significantly 
associated with IL-1  levels in women, with a borderline significant association (p = 0.053) 
in men ( table 4 ).
 In both genders, IL-6 levels increased with greater levels of BMI, waist circumference, 
and %body fat. After multivariate adjustment, these associations remained significant in 
women while in men only the association with abdominal obesity remained significant 
 ( table 2 ). In both genders, all obesity markers were individually and positively correlated 
with IL-6 levels ( table 4 ), but this association was no longer significant after multivariate 
ridge regression ( table 4 ).
 In both genders, TNF-  levels increased with greater levels of BMI, waist circumference, 
and %body fat ( table 3 ); after multivariate adjustment these associations remained signif-
icant in women while in men only the association with abdominal obesity remained signif-
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icant ( table 3 ). Taken individually, all obesity markers were significantly and positively 
correlated with TNF-  . Conversely, after multivariate ridge regression only BMI (in women) 
and waist circumference (in men) were significantly and positively associated with TNF-  
( table 4 ).
 In both genders, hs-CRP levels increased with greater levels of BMI, waist circum-
ference, and %body fat,  and these associations remained significant after multivariate 
adjustment ( table 3 ). All obesity markers were significantly and positively associated with 
hs-CRP, both on bivariate correlation or on multivariate ridge regression ( table 4 ).
 Discussion 
 To our knowledge, this is currently the largest population-based sample in which the 
associations between different obesity markers and IL-1  , IL-6, TNF-  , and hs-CRP have 
been assessed. Further, most studies  [6, 7] assessed the independent associations of each 
obesity marker with cytokine levels by multivariate linear regression , which is prone to 
error when the independent variables are correlated In this study , the results of the linear 
regression were confirmed by a method which corrects for such a correlation and by using 
log-transformed values to reduce skewness.
 IL-1  comes from the interleukin 1 family, which comprises 11 different proteins 
encoded by 11 distinct genes. In mice, IL-1 induces anorexia  [20] , although no differences in 
Table 1. C linical characteristics of the sample, by gendera
Men (N = 2,863) Women (N = 3,167) Test
Age, years 52.6 8 10.8 53.5 8 10.7 3.52***
Smoking status (%)
Never 921 (32.2) 1,496 (47.2)
Former 1,106 (38.6) 887 (28.0) 147.6***
Current 836 (29.2) 784 (24.8)
Leisure-time physical activity (%) 1,838 (64.2) 2,058 (65) 0.40 NS
BMI, kg/m2 26.6 8 4.0 25.1 8 4.8 12.77***
BMI categories (%)
Normal 1,078 (37.7) 1,812 (57.2)
Overweight 1,306 (45.6) 902 (28.5) 246.4***
Obese 479 (16.7) 453 (14.3)
Waist circumference, cm 96 8 11 83 8 12 40.30***
Abdominal obesity (%) 681 (23.8) 974 (30.8) 36.67***
%Body fat 23.8 8 6.1 34.3 8 8.2 56.20***
Dosable IL-1 (%) 132 (60.5) 225 (63.9) 7.60**
IL-1, pg/ml 1.10 (0.45–3.97) 1.28 (0.52–3.76) 3.65NS
Dosable IL-6 (%) 278 (93.5) 206 (91.8) 6.95**
IL-6, pg/ml 1.58 (0.77–3.85) 1.37 (0.67–3.23) 19.68***
Dosable TNF- (%) 244 (99.3) 343 (99.2) 0.19NS
TNF-, pg/ml 3.06 (1.90–4.66) 2.75 (1.73–4.42) 23.65***
hs-CRP, mg/dl 1.2 (0.6–2.5) 1.3 (0.6–2.9) 6.74**
a Results are expressed as mean 8 standard deviation (except cytokines), median and (interquartile 
range) of dosable values (cytokines) or as number of subjects and (percentage). Statistical analysis by 
Student’s t-test or Kruskall-Wallis nonparametric test for quantitative variables and by chi-square for 
qualitative variables: NSnot significant; *p < 0.05; **p < 0.01; ***p < 0.001.
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IL-1  levels between patients with anorexia nervosa and normal-weight subjects have been 
found  [21] . In this study, negative associations between IL-1  levels and obesity markers 
were found, with %body fat being the only obesity marker associated with IL-1  levels on 
multivariate analysis in women  with a similar borderline significant (p = 0.053) trend in 
men. The lack of significance among men might be related to a lower statistical power due 
to a small sample size; indeed, the multivariate-adjusted estimate of the slope in men was 
comparable to that in women ( table 4 ). These findings are in agreement with the previously 
reported effect of IL-1 in mice, i.e., lower adipocyte numbers and reduced dietary intake, 
Table 2. I L-1 and IL-6 distribution according to different markers of obesity, by gender1
IL-1 I L-6
values >
LOD (N)a
median (IQR)b multi-
adjustedc
valu es > 
LOD (N)a
median (IQR)b multi-
adjustedc
Men (N = 2,863)
BMI categories §
Normal (n = 1,078) 670 (62.2) 1.24 (0.49–4.50) 1.59 8 1.06 989 (91.7) 1.52 (0.71–3.87) 1.97 8 1.04
Overweight (n = 1,306) 779 (59.7) 1.00 (0.45–3.93) 1.44 8 1.06 1,225 (93.8) 1.50 (0.75–3.67) 1.88 8 1.04
Obese (n = 479) 283 (59.1) 0.94 (0.40–2.89) 1.30 8 1.10 464 (96.9) 1.87 (0.93–4.11) 2.15 8 1.06
Test 2.03NS 6.21* 1.74NS 14.68*** 7.46* 1.72NS
High %body fat§§
No (n = 2,157) 1,340 (62.1) 1.15 (0.46–4.13) 1.50 8 1.04 2,004 (92.9) 1.48 (0.71–3.68) 1.90 8 1.03
Yes (n = 706) 392 (55.5) 0.90 (0.43–3.11) 1.38 8 1.08 674 (95.5) 1.90 (0.98–4.21) 2.15 8 1.06
Test 9.69** 3.61NS 0.74NS 5.77* 17.34*** 3.92*
Abdominal obesity§§§
No (n = 2,182) 1,345 (61.6) 1.11 (0.46–4.09) 1.47 8 1.04 2,020 (92.6) 1.49 (0.71–3.70) 1.89 8 1.03
Yes (n = 681) 387 (56.8) 1.00 (0.43–3.34) 1.46 8 1.08 658 (96.6) 1.90 (0.94–4.27) 2.19 8 1.05
Test 5.03* 0.75NS 0.01NS 14.06*** 15.92*** 6.10*
Women (N = 3,167)
BMI categories §
Normal (n = 1,812) 1,179 (65.1) 1.36 (0.55–4.02) 1.57 8 1.05 1,629 (89.9) 1.23 (0.60–3.23) 1.66 8 1.04
Overweight (n= 902) 569 (63.1) 1.20 (0.47–3.74) 1.54 8 1.06 840 (93.1) 1.30 (0.69–2.80) 1.65 8 1.05
Obese (n = 453) 277 (61.2) 1.07 (0.49–2.93) 1.5 8 1.09 437 (96.5) 2.03 (1.03–3.91) 2.34 8 1.07
Test 2.82NS 2.88NS 0.11NS 23.79*** 43.37*** 11.55***
High %body fat§§
No (n = 2,320) 1,512 (65.2) 1.35 (0.53–4.09) 1.59 8 1.04 2,093 (90.2) 1.25 (0.61–3.22) 1.68 8 1.03
Yes (n = 847) 513 (60.6) 1.10 (0.47–3.17) 1.44 8 1.07 813 (96.0) 1.60 (0.88–3.25) 1.93 8 1.05
Test 5.71* 6.06* 1.59NS 27.32*** 18.55*** 5.10*
Abdominal obesity§§§
No (n = 2,193) 1,425 (65.0) 1.37 (0.54–4.08) 1.61 8 1.04 1,978 (90.2) 1.22 (0.60–3.04) 1.63 8 1.03
Yes (n = 974) 600 (61.6) 1.00 (0.47–3.21) 1.43 8 1.06 928 (95.3) 1.70 (0.87–3.54) 2.03 8 1.05
Test 3.34NS 6.63** 2.64NS 23.03*** 34.99*** 15.34***
1Re sults are expressed as number of subjects (percentage) with values above the lower limit of detection (LOD), median 
and interquartile range (IQR) for values above LOD and exponentiated multivariate-adjusted average 8 standard error for 
values above LOD. Statistical analysis by achi-square, bKruskall-Wallis test and cgeneral linear model on log-transformed 
values adjusting for age (continuous), smoking (3 groups), and leisure-time physical activity (2 groups): NSnot significant;
*p < 0.05; **p < 0.01; ***p < 0.001.
§Normal, BMI < 25 kg/m2; overweight, 25 ≤ BMI < 30 kg/m2; obese, BMI ≥ 30 kg/m2.
§§Defined as a %body fat ≥28% in men and ≥40% in women.
§§§Defined as a waist > 102 cm in men and > 88 cm in women. 
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although we have no information on the former. Overall, our results suggest that increased 
IL-1  levels are associated with lower %body fat levels, probably due to a reduced adipocyte 
differentiation.
 It has been estimated that approximately 30% of circulating IL-6 comes from adipose 
tissue  [22] . In this study, obese subjects had higher IL-6 levels, a finding also reported by 
others  [23] . Interestingly, after multivariate adjustment, abdominal obesity was signifi-
cantly associated with IL-6 levels in both genders, a finding which is in agreement with 
recent literature  [7, 24] . Still, although all obesity markers were significantly and positively 
correlated with IL-6 levels in both genders, these associations were no longer significant 
Table 3. T NF- and CRP distribution according to different markers of obesity, by gender1
TNF- C RP
values >
LOD (N)a
median (IQR)b multi-
adjustedc
values  >
LOD (N)a
median (IQR)b multi-
adjustedc
Men (N = 2,863)
BMI categories§
Normal (n = 1,078) 1,069 (99.2) 2.87 (1.86–4.37) 3.04 8 1.03 1,078 (100) 0.8 (0.4–1.6) 0.93 8 1.03
Overweight (n = 1,306) 1,298 (99.4) 3.10 (1.90–4.63) 3.12 8 1.02 1,306 (100) 1.4 (0.7–2.7) 1.47 8 1.03
Obese (n = 479) 477 (99.6) 3.46 (2.13–5.48) 3.37 8 1.04 479 (100) 2.2 (1.3–4.3) 2.24 8 1.05
Test 0.97NS 19.32*** 2.45NS NA 343.3*** 140.6***
High %body fat§§
No (n = 2,157) 2,144 (99.4) 2.94 (1.87–4.46) 3.10 8 1.02 2,157 (100) 1.0 (0.5–2.1) 1.17 8 1.02
Yes (n = 706) 700 (99.2) 3.40 (2.09–5.48) 3.21 8 1.03 700 (100) 2.0 (1.1–4.3) 1.98 8 1.04
Test 0.49NS 15.48*** 0.80NS NA 224.2*** 126.2***
Abdominal obesity§§§
No (n = 2,182) 2166 (99.3) 2.93 (1.86–4.46) 3.04 8 1.02 2182 (100) 1.0 (0.5–2.0) 1.15 8 1.02
Yes (n = 681) 678 (99.6) 3.50 (2.12–5.67) 3.41 8 1.03 681 (100) 2.2 (1.2–4.3) 2.12 8 1.04
Test 0.59 26.48*** 8.66** NA 261.3*** 184.5***
Women (N = 3,167)
BMI categories§
Normal (n = 1,812) 1,797 (99.2) 2.59 (1.64–4.08) 2.78 8 1.02 1,812 (100) 0.8 (0.5–1.8) 0.95 8 1.03
Overweight (n = 902) 897 (99.5) 2.90 (1.77–4.62) 2.96 8 1.03 902 (100) 1.9 (0.9–3.6) 1.88 8 1.03
Obese (n = 453) 449 (99.1) 3.29 (2.12–5.08) 3.43 8 1.04 453 (100) 3.8 (1.9–7.0) 3.53 8 1.05
Test 0.71NS 39.49*** 9.91*** NA 647.8*** 337.5***
High %body fat§§
No (n = 2,320) 2,300 (99.1) 2.59 (1.63–4.16) 2.81 8 1.02 2,320 (100) 1.0 (0.5–2.2) 1.13 8 1.02
Yes (n = 847) 843 (99.5) 3.20 (2.11–4.92) 3.22 8 1.03 847 (100) 2.6 (1.4–5.1) 2.55 8 1.04
Test 1.25NS 48.92*** 12.12*** NA 396.1*** 315.9***
Abdominal obesity§§§
No (n = 2,193) 2,177 (99.3) 2.57 (1.66–4.14) 2.79 8 1.02 2,193 (100) 1.0 (0.5–2.1) 1.08 8 1.02
Yes (n = 974) 966 (99.2) 3.20 (2.04–5.01) 3.22 8 1.03 974 (100) 2.6 (1.4–5.2) 2.51 8 1.04
Test 0.08 NS 48.11*** 16.27*** NA 462.6*** 410.0***
1Re sults are expressed as number of subjects (percentage) with values above the lower limit of detection (LOD), median 
and interquartile range (IQR) for values above LOD and exponentiated multivariate-adjusted average 8 standard error for 
values above LOD. Statistical analysis by achi-square, bKruskall-Wallis test and cgeneral linear model on log-transformed 
values adjusting for age (continuous), smoking (3 groups), and leisure-time physical activity (2 groups): NSnot significant;
*p < 0.05; **p < 0.01; ***p < 0.001.
§Normal, BMI < 25 kg/m2; overweight, 25 ≤ BMI < 30 kg/m2; obese, BMI ≥ 30 kg/m2.
§§Defined as a %body fat ≥28% in men and ≥40% in women.
§§§Defined as a waist > 102 cm in men and > 88 cm in women. 
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after multivariate ridge regression. Our results are partly in agreement with one study  [25] 
which found no significant correlation between abdominal fat distributions measured by 
ultrasonography and circulating IL-6 levels. Conversely, the lack of association between 
%body fat and IL-6 levels is not in agreement with a previous study  [7] . A possible expla-
nation for this discrepancy is that the previous study included only obese subjects, thus 
limiting the generalization of the findings. Overall, our results suggest that abdominal 
obesity is associated with increased IL-6 levels in both genders, but that this increase in IL-6 
levels is not mediated by any specific obesity marker (BMI, waist circumference, or %body 
fat). Nevertheless, further studies are needed to better assess the specific effects of selected 
obesity markers on IL-6 levels.
 TNF-  is mainly secreted by macrophages after stimulation by bacterial lipopolysac-
charides and stimulates the production of other cytokines such as IL-6  [24] . Adipocytes 
have also been shown to produce TNF-   [26] , and high TNF-  levels have been found in 
obese subjects  [27] . In both genders, subjects with abdominal obesity had higher TNF-  
levels, and these differences persisted after multivariate adjustment; conversely, increased 
BMI and %body fat were associated with increased TNF-  levels in women only. Only BMI 
Table 4. R elationships between inflammatory and obesity markers, by gender1
IL-1 IL-6 TNF- hs-CRP
Men (N) 1,732 2,678 2,844 2,862
Spearman correlation
BMI –0.057NS 0.053** 0.095*** 0.359***
%Body fat –0.079** 0.072*** 0.114*** 0.365***
Waist circumference –0.063** 0.074*** 0.122*** 0.381***
Linear regressiona
BMI –0.011 (0.009)NS 0.015 (0.006)* 0.012 (0.004)** 0.082 (0.005)***
%Body fat –0.015 (0.007)* 0.005 (0.005)NS 0.007 (0.003)* 0.055 (0.004)***
Waist circumference –0.003 (0.003)NS 0.007 (0.002)** 0.006 (0.001)*** 0.031 (0.002)***
Ridge regressionb
BMI –0.002 (0.020)NS –0.001 (0.014)NS –0.004 (0.009)NS 0.025 (0.010)*
%Body fat –0.019 (0.010)NS –0.007 (0.007)NS –0.001 (0.004)NS 0.019 (0.005)***
Waist 0.004 (0.007)NS 0.009 (0.005)NS 0.008 (0.003)* 0.016 (0.004)***
Women (N) 2,025 2,906 3,143 3,167
Spearman correlation
BMI –0.048NS 0.095*** 0.122*** 0.475***
%Body fat –0.082*** 0.080*** 0.122*** 0.433***
Waist circumference –0.055NS 0.109*** 0.141*** 0.462***
Linear regression a
BMI –0.005 (0.007)* 0.026 (0.005)*** 0.019 (0.003)*** 0.106 (0.004)***
%Body fat –0.010 (0.004)NS 0.010 (0.003)** 0.006 (0.002)** 0.058 (0.003)***
Waist circumference –0.004 (0.003)NS 0.011 (0.002)*** 0.007 (0.001)*** 0.040 (0.002)***
Ridge regression b
BMI 0.029 (0.015)NS 0.020 (0.012)NS 0.021 (0.007)** 0.055 (0.008)***
%Body fat –0.017 (0.006)** –0.007 (0.005)NS –0.007 (0.003)* 0.017 (0.004)***
Waist circumference –0.007 (0.005)NS 0.007 (0.004)NS 0.003 (0.003)NS 0.015 (0.003)***
1 Only for participants with values above lower levels of detection. All analyses were performed on log-
transformed variables, adjusting for age, smoking status and leisure-time physical activity. For linear and 
ridge regression, results are presented as slope (standard error): NSnot significant; *p < 0.05; **p < 0.01; 
***p < 0.001.
aFor each obesity marker separately. bAll obesity markers taken together. 
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(in women) and waist circumference were independently and positively associated with 
TNF-  levels, a result which is partly in agreement with some smaller studies  [23] but not 
with others  [24, 25] . Again, no independent association between %body fat and TNF-  levels 
was found, a finding in contradiction with a previous study  [7] . In women, BMI, but not waist 
circumference, was associated with TNF-  , a finding which is in agreement with another 
study  [25] . Finally, obese subjects have a higher prevalence of diabetes, a condition which 
increases inflammatory markers. Still, further adjustment on diabetic status (defined as 
fasting plasma glucose  6 7 mmol/l and/or presence of antidiabetic treatment) did not 
change the results (supplementary tables 1 and 2). Overall, our results suggest that both 
BMI and waist circumference might be associated with an increased production of TNF-  , 
while the effect of %body fat awaits further investigation.
 CRP is an acute-phase reactant mainly synthesized in the liver. Several studies have 
shown that hs-CRP is associated with most obesity markers  [7] . Indeed, all obesity markers 
were significantly and positively associated with hs-CRP levels, but likely due to differing 
metabolic pathways. For instance, the high fat mass (overall or in the abdominal region) 
might lead to increased production of TNF-  and IL-6, which in turn increase hepatic 
production of hs-CRP  [28] , while the relationship with BMI could be simply due to increased 
arthritis or hyperuricemia  [29] .
 The major strength of our study is that we used a large, population-based sample repre-
sentative of the Swiss population, that a precise characterization of the participants was 
performed, and that we used a statistical method correcting for correlations amongst inde-
pendent variables. However, we should also mention some limitations of our study. Although 
the participation rate was similar to other epidemiological studies  [30] , it was rather low 
(41%), which might limit the generalization of findings. It has also been shown that African 
Americans have lower visceral adipose tissue but similar or higher concentrations of inflam-
matory biomarkers than Caucasians  [31] ; as only data from Caucasian subjects was analyzed, 
our findings may not apply to other ethnicities. Further, all measures of association 
(Spearman correlations, linear or ridge regression coefficients) were relatively low for all 
inflammatory markers, except for hs-CRP, suggesting that obesity markers exert only a 
modest impact on IL-1  , IL-6, and TNF-  levels.
 In summary, our results suggest that obesity markers are significantly, moderately and 
differentially associated with cytokine levels. %Body fat is negatively associated with IL-1  
levels; abdominal obesity is associated with increased IL-6 levels in both genders, but that 
this increase in IL-6 levels is not mediated by any specific obesity marker; both BMI and 
waist circumference are associated with an increased production of TNF-  , while the effect 
of %body fat awaits further investigation. Conversely, all obesity markers are strongly asso-
ciated with hs-CRP levels.
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